Star Combo Pharma’s recent Interview with The Australian Financial Review

On 29^th May 2024, Ms. Su Zhang CEO of Star Combo Pharma Ltd, was interviewed by The Australian Financial Review.

In the Interview, Ms Su Zhang announced a multimillion-dollar upgrade to their Sydney plant and expressed that a corporate tax cut would enable further investments in AI-driven digital manufacturing. The company, which employs about 100 people, recently received approval to produce gummy vitamins and aims to expand further with the right policies.

To view the full article, please click here.